Glycoprotein B genotyping in congenital/perinatal cytomegalovirus infection in symptomatic infants

Indian Pediatrics

Volumn 50, Issue 7, 2013, Pages 663-667

  Gandhoke, Inderjeet ^a   Hussain, S Akhtar ^b   Pasha, S T ^c   Chauhan, L S ^d   Khare, Shashi ^a  

^a National Centre for Disease Control   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^c DGHS ^*  (India)

^d NCDC   (India)

Author keywords

Cytomegalovirus; Epidemiology; gB genotypes; Glycoprotein B; India

Indexed keywords

GENOMIC DNA; GLYCOPROTEIN B; IMMUNOGLOBULIN M; RESTRICTION ENDONUCLEASE; GLYCOPROTEIN B, SIMPLEXVIRUS; VIRUS ENVELOPE PROTEIN;

ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DNA ISOLATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; GENE TARGETING; GENOTYPE; HEPATOSPLENOMEGALY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NEWBORN; NUCLEOTIDE SEQUENCE; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROLOGY; URINALYSIS; VIRUS STRAIN; BLOOD; CYTOMEGALOVIRUS INFECTIONS; GENETICS; INCIDENCE; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NEWBORN DISEASE; VIROLOGY;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MOLECULAR SEQUENCE DATA; VIRAL ENVELOPE PROTEINS;

EID: 84880314484     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-013-0199-5     Document Type: Article

References (30)

1. Friedman S, Ford-Jones EL. Congenital cytomegalovirus infection: an update. Pediatr Child Health. 1999;4:35-38.
2. Benjamin Bar-Oz, Berkovitch M, Lee Ford-Jones, Koren G. Congenital cytomegalovirus infection: Is there a breakthrough? Canadian Family Physician. 2001;47: 1179-1181.
3. Grillner L, Ahlfors K, Ivarsson SA, Harris S, Svanberg L. Endonuclease cleavage pattern of cytomegalovirus DNA of strains isolated from congenitally infeced infants with neurologic sequelae. Pediatrics. 1988;81:27-30.
4. Peckham CS, Garrett AJ, Chin KS, Preece PM, Nelson DB, Warren DE. Restriction enzyme analysis of cytomegalovirus DNA to study transmission of infection. J Clin Pathol. 1986;39:318-324.
5. Chou S. Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens. J Infect Dis. 1990;162:738-742.
6. Britt WJ, March M. Human cytomegalovirus proteins. Intervirology. 1996:39:401-412
7. Navarro D, Lannette C, Tugizov S, Pereira L. Humoral immune response to Functional Regions of human cytomegalovirus Glycoprotein BJ Med Virol. 1997;52:451-459.
8. Chou SW, Denninson KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis.1991; 163:1229-1234.
9. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Inf Dis. 1996;174: 184-187.
10. Trincado DE, Scott GM, White PA, Hunt C, Rasmussen l, Rawlinson WD. Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol 2000;61:481-487.
11. Fries BC, Chou S, Boeckh M, Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis. 1994;169:769-774.
12. Vogelberg C, Meyer-Koni U, Hufert FT, Kirste G, Von Laer D. Human Cytomegalovirus glycoprotein B genotype in renal transplant recipients. J Med Viro. 1996;50:31-34.
13. Rai A, Kumari S, Khare S, Gandhoke I., Bhatia R, Datta KK. Maternal viral infections and their implications in congenital defects of new borns. J Basic and Applied Biomedicine. 1995;3:1-9.
14. Jindal S, Aggarwal N. A pilot seroepidemiological study of cytomegalovirus infection in women of child bearing age. Indian J Med Microbiol. 2005;23:34-36.
15. Chakravarty A, Kashyap B, Rathi K. The seroepidemiological study on cytomegalovirus in women of child-bearing age with special reference to pregnancy and maternal-fetal transmission. Indian J Pathol Microbiol. 2005;48:518-521.
16. Abraham M, Abraham P, Jana AK, Kuruvilla KA, Cherian T, Moses PD, Mathai E, John TJ, Sridharan G. Serology in congenital infections: experience in selected symptomatic infants. Indian J Pediatr. 1999;36:697-700.
17. Gandhoke I, Aggarwal R, Lal S, Khare S. Congenital CMV infection in symptomatic infants in Delhi and surrounding areas. Indian Journal of Pediatrics. 2006;73:1095-1097.
18. Rekha S, Chandrasekhra MK, Yeshwanth M. Cytomegalovirus infection acquired through blood transfusions. Indian Pediatr. 1995;32:575-577.
19. Aldo De Albuquerque Cunha, Lauro Juliano Marin, Victor Hugo Aquino, Luiz Tadeu Moraes Figueiredo. Diagnosis of cytomegalovirus infections by qualitative and quantitative pcr in hiv infected patients. Rev Inst Med Trop S Paulo. 2002;44:127-132.
20. Ho M. Cytomagalovirus. In: Mandell GL, Douglas RG, Bennett JE. (Eds.) Principles and Practice of Infectious Diseases. Third Edition. Chuchill Livingstone, New York, 1990, p. 1159-1172.
21. Ahlfors K, Ivarsson SA, Harris S. Svanberg L, Holmqvist R, Lenmark B, et al. Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary maternal infections. Scand J Infect Dis. 1984;16:129-138.
22. Ahumada-Ruiz S, Taylor-Castillo S, Visona K, Luftig RB, Herrero-Uribe L. Determination of human cytomegalovirus genetic diversity in different Patient Populations in Costa Rica. Rev Inst Med Trop S Palo. 2004;46:87-92.
23. Zhong Sheng, Chao Chun Zou, Ji Yan Zheng, Yan Zhao. Cytomegalovirus gB genotypes and clinical features in Chinese Infants with Congenital Infections. Intervirology. 2006; 49:281-285.
24. Sowmya P, Dhanya V, Madhavan HN, Therese KL. Comparative efficacy of PCR-based restriction fragment length polymorphism (RFLP) and multiplex PCR for glycoprotein B (gB) genotyping of human cytomegalovirus. Indian J Med Res. 2007;126:122-127.
25. Novak Z, Ross SA, Patro RK, Pati SK, Kumbla RA, Brice S, et al. Cytomegalovirus strain diversity in seropositive women. J Clinical Microb 2008; 882-886
26. Lukácsi A, Tarodi B, Endreffy E, Bábinszki A, Pál A, Pusztai R, et al. Human cytomegalovirus gB genotype 1 is dominant in congenital infections in South Hungary. J Med Virol. 2001;65:537-542.
27. Barbi M, Binda S, Carropo S, Primache V, Didò P, Guidotti P, et al. CMV gB genotypes and outcome of vertical transmission: Studies on dried blood spots of congenitally infected babies. J Clin Virol. 2001;21:75-79.
28. Manning FJ, Swaetz M (Eds.) Clinical Trials. Review of the fialuridine (FIAU) clinical trials: National Academy Press. 1995.
29. Gonczol E and Plotkin S. Development of a cytomegalovirus vaccine: lessons from recent clinical trials. Exp Opin Biol Therap. 2001;1:401-412.
30. Pas RE, Burke RL Development of Cytomegalovirus Vaccines: prospects for prevention of congenital CMV infection. Semn Pediatr Infect Dis. 2002;13:196-204.